Follow us on FacebookFollow TorHoermanLaw on TwitterEmail Tor Hoerman Law

Marseilles IL Flooding Update

Months after historic floods hit Marseilles, IL, the word that strikes us about this community is resilience. There is no other way to describe a community that works so hard to help neighbors dig out from damages suffered during the floods so they can go back to the life they knew as proud community members of Marseilles, a small town with a prime… Read more

HeartBleed Help from an Amateur

 

Okay, I’ll admit it, I have been known to use “password” on a few sites – on occasion a site requires me to add numbers or even capitalize which results a capitalized “P” and an occasional number at the end. Tricky, huh? So, given the immense amount of news in the past 24 hours that was clearly designed to keep… Read more »

Marseilles IL Flooding Update

 

Months after historic floods hit Marseilles, IL, the word that strikes us about this community is resilience. There is no other way to describe a community that works so hard to help neighbors dig out from damages suffered during the floods so they can go back to the life they knew as proud community members of Marseilles, a small town with a prime… Read more »

Federal Law Does Not Prevent Plaintiff's Failure to Warn Claims in Chicago Actos Litigation

 

This morning in preparation of the first Actos trial in Cook County, Judge Deborah Dooling heard oral arguments from both parties on Takeda Pharmaceutical's Motion for Partial Summary Judgment based upon federal preemption. Ken Brennan of TorHoerman Law argued for the Plaintiffs and cited numerous cases and regulations for the conclusion that federal… Read more »

First Actos MultiDistrict Litigation Case Begins Today

 

Today begins the first Actos MDL case in the US District Court, Western District of Louisiana. Jury was selected on Friday and today begins opening statements in the case of Terrence Allen, a man who was diagnosed with bladder cancer in January 2011 after taking Actos pursuant to a prescription starting in June 2006. Mr. Allen’s lawsuit claims… Read more »

Seventh Circuit Court of Appeals Calls Boehringer Ingelheim Order "Weak Kneed"

 

In a dissent that reads like an angry mother grounding a child for complaining about punishments provided by dad, Judge Hamilton tells Boehringer Ingelheim (hereinafter Boehringer) that the petitioner-defendant’s use of a procedure referred to as a “writ of mandamus” was weak-kneed. A “writ of mandamus” is an extraordinary… Read more »

Actos Cases Move Ahead Rules MDL Judge

 

On January 7, 2014, Judge Doherty, the Louisiana federal judge assigned to the multidistrict litigation (MDL) In Re:Actos, denied a Motion for Partial Summary Judgment filed by Takeda Pharmaceuticals. In ruling for the plaintiffs, Judge Doherty found that the plaintiffs did in fact satisfy their burden to show that the facts and circumstances of this case warrants the Actos cases to move forward towards a day in court. Read more »

Drug used to Treat Lennox-Gastaut Syndrome Linked to Severe Skin Reactions

 

FDA warns that anti-seizure drug Onfi can cause rare but serious skin reactions that can result in permanent harm and death. Read more »

Research Mounts Between Increased Risk of Pancreatic Cancer and the Type 2 Diabetes Drug Class Known as Incretin Mimetics

 

Scientific journals, studies and advocacy groups join the FDA in questioning the safety of the Type 2 diabetes drug class referred to as incretin mimetics, which includes brand name drugs such as Byetta, Bydureon, Victoza, Januvia and Janumet. Read more »

Despite One Loss, Juries and Regulatory Agencies Continue To Quetion Safety of Actos

 

Three Actos trials have made their way through courtrooms with two juries finding Takeda guilty of a negligence to warn and one jury finding for Takeda.  Large litigations such as the Actos litigation will see some losses with different factual situations.  The jury loss yesterday does not change the fact that Actos increases the risk of bladder cancer.  The FDA and a few independent agencies have stated as much and, while Actos is currently on the market in the U.S., several countries have taken it off the market. Read more »

Pancreatic Cancer from Diabetes Drugs Litigation Moves Forward

 

As lawsuits move forward, individuals diagnosed with pancreatitis or pancreatic cancer after taking type 2 diabetes medications are advised to determine their legal rights - fill out this survey for a quick, no cost/obligation legal consultation.   Read more »

THL is "Tank Full" for the Main Street Community Center

 

TorHoerman Law is proud to sponsor the Main Street Community Center (MSCC) Tank Full Trivia event. All proceeds for this event benefit a door-to-door transportation program for seniors and the disabled in the community.  Read more »

Is the FDA's Safety Data for Pradaxa Trustworthy?

 

Shortly after FDA approval in October of 2012, adverse events mounted for the anticoagulant, Pradaxa and as of October of 2013, it was the single most-reported drug.  Critics now question the data used to inform patients and doctors about the safety and efficacy of Pradaxa.   Read more »

Diabetes Drugs Pancreatic Cancer Litigation Proceeds - THL Attorneys Named as Leaders

 

Tor Hoerman and Jake Plattenberger named to leadership roles in diabetes drugs pancreatic cancer lawsuit consolidated in front Judge Anthony J. Battaglia in the Southern District of California. Read more »

Marseilles Flooding Lawsuit Update

 

Six months after the devastating flooding that forced the evacuation of 1,500 Marseilles residents, TorHoerman Law continues to work toward finding justice for residents experiencing near devastation when seven barges owned by Ingram Barge company slammed into the I & M dam. Like many other things, our work on this case was affected by… Read more »

Vaginal Mesh Manufacturers Begin Settlement Discussions

 

After several plaintiffs were awarded million dollar verdicts and others settled for undisclosed amounts, five of the largest transvaginal mesh manufacturers have begun discussing settlement for the thousands of remaining plaintiffs. Read more »

 

1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19   Next »

No-Obligation Free Consultation

Contact us by phone at 1-888-50-TORLAW or email us below.


 

Your information will be used only so that we may contact you to evaluate your case. Your contact information will never be shared or sold to anyone other than TorHoerman Law.